Skip to main content
TipRanks
Go Ultimate75% OFF

ExpreS2ion Biotech Holding AB (5JD0) AI Stock Analysis

2 Followers
DE:5JD0

ExpreS2ion Biotech Holding AB

(Frankfurt:5JD0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Proprietary protein platformA proprietary expression platform that handles difficult-to-express proteins can differentiate ExpreS2ion from providers with more limited capabilities. Its relevance across vaccines, diagnostics, pharmaceutical customers, and research supports multiple commercial applications over the medium term.
Negative Factors
Persistent unprofitabilityPersistent losses and deeply negative gross profit show that the current revenue base does not cover the company’s cost structure. Without a material improvement in gross margin and operating efficiency, revenue growth alone may not translate into breakeven or durable earnings.

ExpreS2ion Biotech Holding AB (5JD0) vs. iShares MSCI Germany ETF (EWG)

-100%-75%-50%-25%0%25%DE:5JD0-89.98%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 3.52M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.2
Beta (1Y)
3.53
Revenue Growth
29.66%
EPS Growth
60.08%
Country
Germany
Employees
19
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

ExpreS2ion Biotech Holding AB Business Overview & Revenue Model

Company Description

Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipelin...

ExpreS2ion Biotech Holding AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:5JD0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:CANTASE:CANTA61NeutralSEK 391.34M2.0463.09%―――
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:BINVSE:BINV49NeutralSEK 191.82M-0.39-128.54%―-83.67%-50.29%
SE:XBRANESE:XBRANE46NeutralSEK 235.93M-6.34-11.52%―-38.80%-120.18%
SE:IMMUSE:IMMU39UnderperformSEK 276.26M-2.43-19.14%――13.06%
SE:IVACCSE:IVACC39UnderperformSEK 229.71M-2.23-43.10%―-17.73%18.97%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:5JD0SE:BINVSE:XBRANESE:IVACCSE:IMMUSE:CANTADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:5JD0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:5JD0ExpreS2ion Biotech Holding AB0.06-0.50-89.46%
SE:BINVBioInvent International AB2.92-26.98-90.25%
SE:XBRANEXbrane Biopharma AB11.451.3913.82%
SE:IVACCIntervacc AB0.67-0.22-24.78%
SE:IMMUImmunicum AB4.36-1.30-23.06%
SE:CANTACantargia AB1.39-2.06-59.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.